Nelipak appoints Pat Chambliss as CEO alongside Roger Prevot remaining as Board Chairman

– USA, RI –  Nelipak Corporation, a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, today announced the appointment of Pat Chambliss as CEO, succeeding Roger Prevot who remains Chairman of the Board of Directors, a position he has held since the acquisition of Nelipak by Kohlberg & Company in July 2019.

Pat Chambliss, current President, and COO brings to the CEO role an extensive track record of senior leadership experience in the packaging industry, including previous roles at Packaging Dynamics Corporation and Novolex.

Pat Chambliss commented, “I look forward to leading Nelipak into the next phase of its development with a continued drive to excellence in innovation, growth, and operational execution.”

Roger Prevot said, “I’ve had the opportunity to work alongside Pat for many years, and his distinguished track record and strong professional and personal values make him an outstanding successor to lead Nelipak into the future. I am proud of the accomplishments we have achieved at Nelipak and I am excited to see continued success under Pat’s leadership.”

Seth Hollander, Partner of Kohlberg, commented, “On behalf of the Board of Directors of Nelipak, I wish to sincerely thank Roger for his distinguished service to the company and look forward to his continued role as Chairman of the Board of Directors. Roger has been instrumental in the creation of the current Nelipak and integration of the former European Healthcare Packaging business of Bemis Corporation. As a result of his vision, Nelipak is well-positioned to continue to execute upon transformational initiatives and drive continued excellence.” Hollander continued, “As President and COO, Pat has been instrumental in leading day-to-day operations including initiatives which position the business for future growth through internal investment and strategic acquisitions. Pat’s promotion to CEO is a natural progression that reflects his successful leadership at Nelipak. We are excited for him to step into the CEO role and lead Nelipak through its next phase of growth.”

About Nelipak Healthcare Packaging

Nelipak Healthcare Packaging is a leading global manufacturer of custom-designed rigid and flexible healthcare packaging used for Class II and Class III medical devices, and pharma drug delivery products. The company operates strategically located cleanroom facilities meeting customers’ most stringent packaging requirements. Nelipak’s experienced in-house design, development, prototyping, manufacturing, and quality teams offer medical trays and blisters, surgical procedure trays, flexible sterile tray kidding, and barrier pouches, pharmaceutical handling trays, custom built sealing machines, and other value-added services. With a staff of over 1,400, the company operates from ten production facilities, five in the Americas (Cranston, RI.; Whitehall, PA; Phoenix, AZ.; Humacao, Puerto Rico; and San Jose, Costa Rica) and five in Europe (Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; and Elsham, England).

For more information: https://www.nelipak.com/

About Kohlberg & Company, LLC

Kohlberg & Company, LLC is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized nine private equity funds, through which it has raised over $10 billion of committed equity capital. Over its 33-year history, Kohlberg has completed 82 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value above $20 billion.

For more information: https://www.kohlberg.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team